Even though follicular lymphoma is a lymphoma subtype with high BCL-2 expression in virtually all cases, anti-lymphoma efficacy of single-agent venetoclax this lymphoma subtype was rather disappointing (see above). The gene discussed is BCL2; the disease is follicular lymphoma.